Oneview Healthcare PLC (ASX: ONE) Share Price and News

Mr Fitter has helping transition what was then a 10 person start up into a publicly traded Company in just over three years. He has over 25 years' experience in the global financial markets during which time he has lived and worked on four continents. James founded and managed an independent asset management company and spent over ten years as a professional investor and an independent advisor prior to joining Oneview.

Mr Rooney assumed the role of Interim Chairman in July 2023, subsequent to the retirement of Michael Kaminski. Joseph had taken on this role before, upon the death of our first Chairman, James Osborne. Joseph is also Chair of Fundraising for the Clongowes Wood College Foundation. Until the end of 2012, Joseph was a partner and global strategist at Autonomy Capital Research LLP, a global macro hedge fund. Prior to this, he held a number of senior positions at Lehman Brothers Inc, including Managing Director, Head of Global Strategy and trustee of their UK pension fund.

Mr Cullen is rejoining the Board after recently retiring from a distinguished 30 year career with Deutsche Bank and DWS Asset Management, most recently as CEO of DWS Americas & COO of DWS Group GmbH & Co. Mark was previously the Global Head of Audit for Deutsche Bank from March 2015 to December 2018. Mark was appointed to the Board in October 2023.

Ms Asaria is a corporate board member, advisor and C level global executive with a track record of driving high growth in private and public companies across the health, fintech and mobile industries. She is an advisor to SimBioSys (a spacial biophysics company using AI and data science to drive precision medicine and better outcomes for breast cancer patients), Cylerity (using AI to provide cash advance and revenue recovery to the healthcare industry), InTech Energy (software and hardware solution for air purification and quality and energy expense management) and ExtoLabs (applying blockchain and AI into combined hardware and software platform for financial and healthcare inclusion). Nashina was Chief Product & Marketing Officer (CPMO) for Nanthealth. Prior to Nanthealth, she was CPMO of UpHealth Inc. Nashina was Chief Product Officer at Cloudbreak Health LLC, a US telehealth company that was merged into UpHealth Inc. in June 2021. She has held leadership roles with LifeQ, Nantworks, Verifone and Qualcomm. Nashina was appointed to the Board in 2021.

Ms Nelson is a public board director and C level technology leader, who currently serves on four corporate boards. She has been CEO twice and led global P&Ls as large as US$4 billion in companies ranging from Fortune 500 leaders to VC-funded companies. Barbara has scaled from concept to over US$100 million -US$200 million, four times in three companies, delivering profitability each time. She brings over 15 years of Board, P&L and general management experience in AI, SaaS/cloud services, IaaS, cybersecurity, board, software, mobile, video, data management, storage, IT infrastructure, and semiconductors.

-

-